South Wales, Nov. 20 -- UK Intellectual Property Office has received a patent application (GB2611037.9) with the title ‘Programmable Bacterial Platform for Homologous Isolate-Driven Bloodstream Decontamination and Success-Triggered Metabolic Control (BACT-ERISER™ Platform).’

Here are the other details related to the patent application:

Status: Not in force

Filing Date: 2026-05-12

Owner(s): NANOBIOMATRIX LTD

Disclaimer: Curated by HT Syndication.